Alembic Pharmaceuticals receives USFDA approval for Ticagrelor Tablets, 60 mg EP News Bureau Oct 29, 2025 Approval aligns Ticagrelor 60 mg with its reference drug Brilinta; estimated market size at US$ 236 million
